-- Chad M Robins, Director, Chief Executive Officer and Chairman, on April 06, 2026, sold 120,595 shares in Adaptive Biotechnologies (ADPT) for $1,766,839. Following the Form 4 filing with the SEC, Robins has control over a total of 2,180,518 common shares of the company, with 2,180,518 shares held directly.
SEC Filing:
https://www.sec.gov/Archives/edgar/data/1478320/000178064926000011/xslF345X05/form4.xml